Skip to content
The Policy VaultThe Policy Vault

Actemra — Blue Cross Blue Shield of Alabama

Systemic sclerosis associated interstitial lung disease (SSc-ILD)

Initial criteria

  • If Actemra is requested for SSc-ILD, the request is for the Actemra syringe (Actemra ACTpen not approvable for SSc-ILD)

Approval duration

12 months